{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T10:27:13Z","timestamp":1771842433160,"version":"3.50.1"},"reference-count":12,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,2,9]],"date-time":"2010-02-09T00:00:00Z","timestamp":1265673600000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Emerg Medicine Australasia"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background:\u2003<\/jats:bold> Intranasal (IN) fentanyl provides rapid and powerful non\u2010parenteral analgesia in the ED. A concentrated solution of fentanyl (300\u2003\u00b5g\/mL) has been used in prior trials, yet many ED use the standard solution at a concentration of 50\u2003\u00b5g\/mL, which is widely available and of low cost. We set out to determine if this lower concentration of fentanyl is also efficacious.<\/jats:p><jats:p><jats:bold>Methods:\u2003<\/jats:bold> Prospective audit in children aged 5\u201318\u2003years presenting with upper limb injuries. Patients received IN fentanyl (50\u2003\u00b5g\/mL) at 1.5\u2003\u00b5g\/kg. Patient assessed pain scores were collected 5, 10, 20, 30 and 60\u2003min following IN fentanyl administration using a visual analogue scale or Bieri Faces \u2013 Revised scale. Parental scores were used if patients were unable to provide a score.<\/jats:p><jats:p><jats:bold>Results:\u2003<\/jats:bold> Of the 59 eligible patients, 36 were enrolled; median age was 6.8\u2003years (range 5\u201315\u2003years), and 89% (32\/36) ultimately required fracture reduction. Median first dose of IN fentanyl was 1.4\u2003\u00b5g\/kg. Median pain scores dropped from 7 (interquartile range 5\u201310) pre\u2010fentanyl to 5 (interquartile range 4\u20138) at 5\u2003min and 2 (interquartile range 1\u20134) at 30 and 60\u2003min. A total of 21 (58%) children did not require further analgesia in the ED. There were no adverse events.<\/jats:p><jats:p><jats:bold>Conclusions:\u2003<\/jats:bold> Standard i.v. concentration IN fentanyl (50\u2003\u00b5g\/mL) appears to have analgesic efficacy in children with upper limb injuries.<\/jats:p>","DOI":"10.1111\/j.1742-6723.2010.01257.x","type":"journal-article","created":{"date-parts":[[2010,2,9]],"date-time":"2010-02-09T07:14:36Z","timestamp":1265699676000},"page":"62-67","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Does the standard intravenous solution of fentanyl (50\u2003\u00b5g\/mL) administered intranasally have analgesic efficacy?"],"prefix":"10.1111","volume":"22","author":[{"given":"Dianne","family":"Crellin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong Xiu","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz E","family":"Babl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,2,9]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2006.06.016"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2005.05.001"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2026.2002.00344.x"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-6723.2009.01207.x"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-6723.2008.01138.x"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2006.110429"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1197\/aemj.9.6.609"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2001.111517"},{"key":"e_1_2_8_10_2","article-title":"Pharmacokinetics of nasal fentanyl","volume":"59","author":"Lim S","year":"2003","journal-title":"J. Pharm. Pract. Res."},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-199812000-00011"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00063110-200312000-00004"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(90)90018-9"}],"container-title":["Emergency Medicine Australasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-6723.2010.01257.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1742-6723.2010.01257.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T16:10:08Z","timestamp":1697386208000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-6723.2010.01257.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1111\/j.1742-6723.2010.01257.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1742-6723.2010.01257.x","archive":["Portico"],"relation":{},"ISSN":["1742-6731","1742-6723"],"issn-type":[{"value":"1742-6731","type":"print"},{"value":"1742-6723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"2010-02-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}